
Biotech Boom: Cell-Based Assays Revolutionizing Drug Development & Precision Medicine
(MENAFN- GlobeNewsWire - Nasdaq) The Cell-Based Assays market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug discovery, ADME/toxicity testing, and precision medicine. These assays …